| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The FASEB Journal, Vol 6, 3362-3369, Copyright © 1992 by The Federation of American Societies for Experimental Biology
REVIEWS |
D Givol and A Yayon
Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.
Since 1989, the receptors for fibroblast growth factors (FGFs) were cloned and characterized as a subgroup of the family of receptor tyrosine kinases. Four FGF receptor genes were identified, all of which encode membrane-bound glycoproteins containing three immunoglobulin (Ig) -like domains at the extracellular region, where only two of these domains are involved in ligand binding. Three unique features characterize the FGF receptors: 1) overlapping recognition and redundant specificity, where one receptor may bind with a similar affinity several of the seven known FGFs and one FGF may bind similarly to several distinct receptors. 2) The binding of FGFs to their receptors is dependent on the interaction of FGF with cell surface heparan sulfate proteoglycans. 3) A multitude of isoforms of cell-bound or secreted receptors are produced by the same gene. The gene structure of these receptors revealed two major mechanisms that are responsible for the formation of the diverse forms: alternative mRNA splicing, resulting in deletions or alternate exons usage, and internal polyadenylation, resulting in truncated products. These are reminiscent of mechanisms that also operate in the immunoglobulin family to generate diversity and to produce either secreted or cell-bound molecules. Tissue-specific alternative splicing in FGF receptors allows for the generation of two distinct receptors from a single gene because alternative exons determine the sequence of the COOH-terminal half of the third Ig-like domain involved in ligand binding. This represents a novel genetic mechanism to generate receptor diversity and specificity and to increase receptor repertoire.
This article has been cited by other articles:
|
|
 |
|
  E. Seli, A. Yaba, O. Guzeloglu-Kayisli, and M. D. Lalioti Alternative splicing of the mouse embryonic poly(A) binding protein (Epab) mRNA is regulated by an exonic splicing enhancer: a model for post-transcriptional control of gene expression in the oocyte Mol. Hum. Reprod., July 1, 2008; 14(7): 393 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Li, M. Jerebtsova, X.-H. Liu, P. Tang, and P. E. Ray Novel cystogenic role of basic fibroblast growth factor in developing rodent kidneys Am J Physiol Renal Physiol, August 1, 2006; 291(2): F289 - F296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Schmidt, D. Ladage, T. Schinkothe, U. Klausmann, C. Ulrichs, F.-J. Klinz, K. Brixius, S. Arnhold, B. Desai, U. Mehlhorn, et al. Basic Fibroblast Growth Factor Controls Migration in Human Mesenchymal Stem Cells Stem Cells, July 1, 2006; 24(7): 1750 - 1758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ben-Zvi, A. Yayon, A. Gertler, and E. Monsonego-Ornan Suppressors of cytokine signaling (SOCS) 1 and SOCS3 interact with and modulate fibroblast growth factor receptor signaling J. Cell Sci., January 15, 2006; 119(2): 380 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Robinson, N. J. Harmer, S. J. Goodger, T. L. Blundell, and J. T. Gallagher Cooperative Dimerization of Fibroblast Growth Factor 1 (FGF1) upon a Single Heparin Saccharide May Drive the Formation of 2:2:1 FGF1{middle dot}FGFR2c{middle dot}Heparin Ternary Complexes J. Biol. Chem., December 23, 2005; 280(51): 42274 - 42282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Ezzat and S L Asa The molecular pathogenetic role of cell adhesion in endocrine neoplasia J. Clin. Pathol., November 1, 2005; 58(11): 1121 - 1125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. St. Bernard, L. Zheng, W. Liu, D. Winer, S. L. Asa, and S. Ezzat Fibroblast Growth Factor Receptors as Molecular Targets in Thyroid Carcinoma Endocrinology, March 1, 2005; 146(3): 1145 - 1153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Yu, L. Zheng, M. Ladanyi, S. L. Asa, and S. Ezzat Sp1-Mediated Transcriptional Control of Fibroblast Growth Factor Receptor 4 in Sarcomas of Skeletal Muscle Lineage Clin. Cancer Res., October 1, 2004; 10(19): 6750 - 6758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kaabeche, J. Lemonnier, S. Le Mee, J. Caverzasio, and P. J. Marie Cbl-mediated Degradation of Lyn and Fyn Induced by Constitutive Fibroblast Growth Factor Receptor-2 Activation Supports Osteoblast Differentiation J. Biol. Chem., August 27, 2004; 279(35): 36259 - 36267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Newman, C.-M. Li, R. Simmons, J. Khosla, and P. L. Sannes Heparin affects signaling pathways stimulated by fibroblast growth factor-1 and -2 in type II cells Am J Physiol Lung Cell Mol Physiol, July 1, 2004; 287(1): L191 - L200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. R. Qian, T. Sano, S. L. Asa, S. Yamada, H. Horiguchi, T. Tashiro, C. C. Li, M. Hirokawa, K. Kovacs, and S. Ezzat Cytoplasmic Expression of Fibroblast Growth Factor Receptor-4 in Human Pituitary Adenomas: Relation to Tumor Type, Size, Proliferation, and Invasiveness J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1904 - 1911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Olsen, O. A. Ibrahimi, A. Raucci, F. Zhang, A. V. Eliseenkova, A. Yayon, C. Basilico, R. J. Linhardt, J. Schlessinger, and M. Mohammadi Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity PNAS, January 27, 2004; 101(4): 935 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Rauchenberger, E. Borges, E. Thomassen-Wolf, E. Rom, R. Adar, Y. Yaniv, M. Malka, I. Chumakov, S. Kotzer, D. Resnitzky, et al. Human Combinatorial Fab Library Yielding Specific and Functional Antibodies against the Human Fibroblast Growth Factor Receptor 3 J. Biol. Chem., October 3, 2003; 278(40): 38194 - 38205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shiba, D. Nishimura, Y. Kawazoe, Y. Onodera, K. Tsutsumi, R. Nakamura, and M. Ohshiro Modulation of Mitogenic Activity of Fibroblast Growth Factors by Inorganic Polyphosphate J. Biol. Chem., July 11, 2003; 278(29): 26788 - 26792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yu, S. L. Asa, R. J. Weigel, and S. Ezzat Pituitary Tumor AP-2{alpha} Recognizes a Cryptic Promoter in Intron 4 of Fibroblast Growth Factor Receptor 4 J. Biol. Chem., May 23, 2003; 278(22): 19597 - 19602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. L. Wu, L. Zhang, T. Yabe, B. Kuberan, D. L. Beeler, A. Love, and R. D. Rosenberg The Involvement of Heparan Sulfate (HS) in FGF1/HS/FGFR1 Signaling Complex J. Biol. Chem., May 2, 2003; 278(19): 17121 - 17129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M-J. Lievens and E. Liboi The Thanatophoric Dysplasia Type II Mutation Hampers Complete Maturation of Fibroblast Growth Factor Receptor 3 (FGFR3), Which Activates Signal Transducer and Activator of Transcription 1 (STAT1) from the Endoplasmic Reticulum J. Biol. Chem., May 2, 2003; 278(19): 17344 - 17349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Shpak, M. B. Lakeman, and K. U. Torii Dominant-Negative Receptor Uncovers Redundancy in the Arabidopsis ERECTA Leucine-Rich Repeat Receptor-Like Kinase Signaling Pathway That Regulates Organ Shape PLANT CELL, May 1, 2003; 15(5): 1095 - 1110. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. Deindl, I. E. Hoefer, B. Fernandez, M. Barancik, M. Heil, M. Strniskova, and W. Schaper Involvement of the Fibroblast Growth Factor System in Adaptive and Chemokine-Induced Arteriogenesis Circ. Res., March 21, 2003; 92(5): 561 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-m. Li, D. Newman, J. Khosla, and P. L. Sannes Heparin Inhibits DNA Synthesis and Gene Expression in Alveolar Type II Cells Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 345 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yu, L. Zheng, S. L. Asa, and S. Ezzat Fibroblast growth factor receptor 4 (FGFR4) mediates signaling to the prolactin but not the FGFR4 promoter Am J Physiol Endocrinol Metab, September 1, 2002; 283(3): E490 - E495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yu, S. L. Asa, and S. Ezzat Fibroblast Growth Factor Receptor 4 Is a Target for the Zinc-Finger Transcription Factor Ikaros in the Pituitary Mol. Endocrinol., May 1, 2002; 16(5): 1069 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Suzuki, Y. Ikegaya, S. Matsuura, Y. Kanai, H. Endou, and N. Matsuki Transient upregulation of the glial glutamate transporter GLAST in response to fibroblast growth factor, insulin-like growth factor and epidermal growth factor in cultured astrocytes J. Cell Sci., March 12, 2002; 114(20): 3717 - 3725. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Santore, Y. Chen, M. J. Smit, and R. Iyengar Adenovirus-directed expression of Q227L-Galpha s inhibits growth of established tumors of later-stage human breast cancer cells in athymic mice PNAS, January 17, 2002; (2002) 32661999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Rozenblatt-Rosen, E. Mosonego-Ornan, E. Sadot, L. Madar-Shapiro, Y. Sheinin, D. Ginsberg, and A. Yayon Induction of chondrocyte growth arrest by FGF: transcriptional and cytoskeletal alterations J. Cell Sci., January 2, 2002; 115(3): 553 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Aviezer, A. P. Seddon, M. J. Wildey, P. Bohlen, and A. Yayon Development of a High Throughput Screening Assay for Inhibitors of Fibroblast Growth Factor-Receptor-Heparin Interactions J Biomol Screen, June 1, 2001; 6(3): 171 - 177. [Abstract] [PDF]
|
|
|
|
|
|
C.-M. Li, J. Khosla, I. Pagan, P. Hoyle, and P. L. Sannes TGF-beta 1 and fibroblast growth factor-1 modify fibroblast growth factor-2 production in type II cells Am J Physiol Lung Cell Mol Physiol, December 1, 2000; 279(6): L1038 - L1046. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Parsons-Wingerter, K. E. Elliott, J. I. Clark, and A. G. Farr Fibroblast Growth Factor-2 Selectively Stimulates Angiogenesis of Small Vessels in Arterial Tree Arterioscler. Thromb. Vasc. Biol., May 1, 2000; 20(5): 1250 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-M. Chen, K. L. Schmeichel, I. S. Mian, S. Lelièvre, O. W. Petersen, and M. J. Bissell AZU-1: A Candidate Breast Tumor Suppressor and Biomarker for Tumor Progression Mol. Biol. Cell, April 1, 2000; 11(4): 1357 - 1367. [Abstract] [Full Text]
|
|
|
|
 |
|
 Z. Vajo, C. A. Francomano, and D. J. Wilkin The Molecular and Genetic Basis of Fibroblast Growth Factor Receptor 3 Disorders: The Achondroplasia Family of Skeletal Dysplasias, Muenke Craniosynostosis, and Crouzon Syndrome with Acanthosis Nigricans Endocr. Rev., February 1, 2000; 21(1): 23 - 39. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Ozaki, M. J. Radeke, and D. H. Anderson Rapid Upregulation of Fibroblast Growth Factor Receptor 1 (flg) by Rat Photoreceptor Cells after Injury Invest. Ophthalmol. Vis. Sci., February 1, 2000; 41(2): 568 - 579. [Abstract] [Full Text]
|
|
|
|
 |
|
 O. Segev, I. Chumakov, Z. Nevo, D. Givol, L. Madar-Shapiro, Y. Sheinin, M. Weinreb, and A. Yayon Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3G380R transgenic mice Hum. Mol. Genet., January 22, 2000; 9(2): 249 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Monsonego-Ornan, R. Adar, T. Feferman, O. Segev, and A. Yayon The Transmembrane Mutation G380R in Fibroblast Growth Factor Receptor 3 Uncouples Ligand-Mediated Receptor Activation from Down-Regulation Mol. Cell. Biol., January 15, 2000; 20(2): 516 - 522. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. PADERA, G. VENKATARAMAN, D. BERRY, R. GODAVARTI, and R. SASISEKHARAN FGF-2/fibroblast growth factor receptor/heparin-like glycosaminoglycan interactions: a compensation model for FGF-2 signaling FASEB J, October 1, 1999; 13(13): 1677 - 1687. [Abstract] [Full Text]
|
|
|
|
|
|
J. DOUKAS, D. K. HOGANSON, M. ONG, W. YING, D. L. LACEY, A. BAIRD, G. F. PIERCE, and B. A. SOSNOWSKI Retargeted delivery of adenoviral vectors through fibroblast growth factor receptors involves unique cellular pathways FASEB J, August 1, 1999; 13(11): 1459 - 1466. [Abstract] [Full Text]
|
|
|
|
|
|
P. Maher p38 Mitogen-activated Protein Kinase Activation Is Required for Fibroblast Growth Factor-2-stimulated Cell Proliferation but Not Differentiation J. Biol. Chem., June 18, 1999; 274(25): 17491 - 17498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D STEINBERGER, U MÜLLER, T H JÜNGER, H P HOWALDT, and P CHRISTOPHIS Mutation of FGFR2 (cys278phe) in craniolacunia and pansynostosis J. Med. Genet., June 1, 1999; 36(6): 499 - 500. [Full Text]
|
|
|
|
|
|
D. A. Pye and J. T. Gallagher Monomer Complexes of Basic Fibroblast Growth Factor and Heparan Sulfate Oligosaccharides Are the Minimal Functional Unit for Cell Activation J. Biol. Chem., May 7, 1999; 274(19): 13456 - 13461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Keresztes and J. Boonstra Import(ance) of Growth Factors in(to) the Nucleus J. Cell Biol., May 3, 1999; 145(3): 421 - 424. [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, M. K. Spatz, K. Kannan, H. Hayk, A. Avivi, M. Gorivodsky, M. Pines, A. Yayon, P. Lonai, and D. Givol A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3 PNAS, April 13, 1999; 96(8): 4455 - 4460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Venkataraman, R. Raman, V. Sasisekharan, and R. Sasisekharan Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex PNAS, March 30, 1999; 96(7): 3658 - 3663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Scheidegger, J. Du, and P. Delafontaine Distinct and Common Pathways in the Regulation of Insulin-like Growth Factor-1 Receptor Gene Expression by Angiotensin II and Basic Fibroblast Growth Factor J. Biol. Chem., February 5, 1999; 274(6): 3522 - 3530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Carl and J Wittbrodt Graded interference with FGF signalling reveals its dorsoventral asymmetry at the mid-hindbrain boundary Development, January 12, 1999; 126(24): 5659 - 5667. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Colin, J.-C. Jeanny, F. Mascarelli, R. Vienet, S. Al-Mahmood, Y. Courtois, and J. Labarre In Vivo Involvement of Heparan Sulfate Proteoglycan in the Bioavailability, Internalization, and Catabolism of Exogenous Basic Fibroblast Growth Factor Mol. Pharmacol., January 1, 1999; 55(1): 74 - 82. [Abstract] [Full Text]
|
|
|
|
|
|
S. L. Asa and S. Ezzat The Cytogenesis and Pathogenesis of Pituitary Adenomas Endocr. Rev., December 1, 1998; 19(6): 798 - 827. [Abstract] [Full Text]
|
|
|
|
|
|
S. Mahr, N. Neumayer, H. J. Kolb, W. Schepp, M. Classen, and C. Prinz Growth Factor Effects on Apoptosis of Rat Gastric Enterochromaffin-Like Cells Endocrinology, October 1, 1998; 139(10): 4380 - 4390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Pye, R. R. Vives, J. E. Turnbull, P. Hyde, and J. T. Gallagher Heparan Sulfate Oligosaccharides Require 6-O-Sulfation for Promotion of Basic Fibroblast Growth Factor Mitogenic Activity J. Biol. Chem., September 4, 1998; 273(36): 22936 - 22942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Guillonneau, M. Bryckaert, C. Launay-Longo, Y. Courtois, and F. Mascarelli Endogenous FGF1-induced Activation and Synthesis of Extracellular Signal-regulated Kinase 2 Reduce Cell Apoptosis in Retinal-pigmented Epithelial Cells J. Biol. Chem., August 28, 1998; 273(35): 22367 - 22373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Arman, R. Haffner-Krausz, Y. Chen, J. K. Heath, and P. Lonai Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development PNAS, April 28, 1998; 95(9): 5082 - 5087. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Saberan-Djoneidi, R. Picart, D. Escalier, M. Gelman, A. Barret, C. Tougard, J. Glowinski, and M. Levi-Strauss A 21-kDa Polypeptide Belonging to a New Family of Proteins Is Expressed in the Golgi Apparatus of Neural and Germ Cells J. Biol. Chem., February 13, 1998; 273(7): 3909 - 3914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Marchese, P Mancini, F Belleudi, A Felici, R Gradini, T Sansolini, L Frati, and M. Torrisi Receptor-mediated endocytosis of keratinocyte growth factor J. Cell Sci., January 12, 1998; 111(23): 3517 - 3527. [Abstract] [PDF]
|
|
|
|
|
|
F. Lovicu and P. Overbeek Overlapping effects of different members of the FGF family on lens fiber differentiation in transgenic mice Development, January 9, 1998; 125(17): 3365 - 3377. [Abstract] [PDF]
|
|
|
|
|
|
H. Kim, D. Rice, P. Kettunen, and I Thesleff FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development Development, January 4, 1998; 125(7): 1241 - 1251. [Abstract] [PDF]
|
|
|
|
|
|
X Xu, M Weinstein, C Li, M Naski, R. Cohen, D. Ornitz, P Leder, and C Deng Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction Development, January 2, 1998; 125(4): 753 - 765. [Abstract] [PDF]
|
|
|
|
|
|
B. Hassel, F. G. Rathjen, and H. Volkmer Organization of the Neurofascin Gene and Analysis of Developmentally Regulated Alternative Splicing J. Biol. Chem., November 7, 1997; 272(45): 28742 - 28749. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Soslow, L. Ying, and N. K. Altorki EXPRESSION OF ACIDIC FIBROBLAST GROWTH FACTOR IN BARRETT'S ESOPHAGUS AND ASSOCIATED ESOPHAGEAL ADENOCARCINOMA J. Thorac. Cardiovasc. Surg., November 1, 1997; 114(5): 838 - 843. [Abstract] [Full Text]
|
|
|
|
|
|
S. Kanda, M. N. Hodgkin, R. J. Woodfield, M. J. O. Wakelam, G. Thomas, and L. Claesson-Welsh Phosphatidylinositol 3'-Kinase-independent p70 S6 Kinase Activation by Fibroblast Growth Factor Receptor-1 Is Important for Proliferation but Not Differentiation of Endothelial Cells J. Biol. Chem., September 12, 1997; 272(37): 23347 - 23353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Melillo, M. Scoccianti, I. Kovesdi, J. Safi Jr, T. Riccioni, and M. C Capogrossi Gene therapy for collateral vessel development Cardiovasc Res, September 1, 1997; 35(3): 480 - 489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ray, A. Baird, and F. H. Gage A 10-amino acid sequence of fibroblast growth factor 2 is sufficient for its mitogenic activity on neural progenitor cells PNAS, June 24, 1997; 94(13): 7047 - 7052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. A. Abbass, S. L. Asa, and S. Ezzat Altered Expression of Fibroblast Growth Factor Receptors in Human Pituitary Adenomas J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1160 - 1166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Ciruna, L Schwartz, K Harpal, T. Yamaguchi, and J Rossant Chimeric analysis of fibroblast growth factor receptor-1 (Fgfr1) function: a role for FGFR1 in morphogenetic movement through the primitive streak Development, January 7, 1997; 124(14): 2829 - 2841. [Abstract] [PDF]
|
|
|
|
|
|
M. Fannon and M. A. Nugent Basic F |
